Targeting CBLB as a potential therapeutic approach for disseminated candidiasis

Y. Xiao, J. Tang, H. Guo, Y. Zhao, R. Tang, S. Ouyang, Q. Zeng, C.A. Rappleye, M.V.S. Rajaram, L.S. Schlesinger, L. Tao, G.D. Brown, Wallace Y. Langdon, B.T. Li, J. Zhang

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

© 2016 Nature America, Inc. All rights reserved.Disseminated candidiasis has become one of the leading causes of hospital-acquired blood stream infections with high mobility and mortality. However, the molecular basis of host defense against disseminated candidiasis remains elusive, and treatment options are limited. Here we report that the E3 ubiquitin ligase CBLB directs polyubiquitination of dectin-1 and dectin-2, two key pattern-recognition receptors for sensing Candida albicans, and their downstream kinase SYK, thus inhibiting dectin-1- and dectin-2-mediated innate immune responses. CBLB deficiency or inactivation protects mice from systemic infection with a lethal dose of C. albicans, and deficiency of dectin-1, dectin-2, or both in Cblb-/- mice abrogates this protection. Notably, silencing the Cblb gene in vivo protects mice from lethal systemic C. albicans infection. Our data reveal that CBLB is crucial for homeostatic control of innate immune responses mediated by dectin-1 and dectin-2. Our data also indicate that CBLB represents a potential therapeutic target for protection from disseminated candidiasis.
Original languageEnglish
Pages (from-to)906-914
Number of pages9
JournalNature Medicine
Volume22
Issue number8
DOIs
Publication statusPublished - 2016

Fingerprint

Candidiasis
Candida albicans
Innate Immunity
Pattern Recognition Receptors
Ubiquitin-Protein Ligases
Candida
Gene Silencing
Therapeutics
Infection
Blood
Phosphotransferases
Genes
Mortality
dectin 1
mouse dectin-2

Cite this

Xiao, Y., Tang, J., Guo, H., Zhao, Y., Tang, R., Ouyang, S., ... Zhang, J. (2016). Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nature Medicine, 22(8), 906-914. https://doi.org/10.1038/nm.4141
Xiao, Y. ; Tang, J. ; Guo, H. ; Zhao, Y. ; Tang, R. ; Ouyang, S. ; Zeng, Q. ; Rappleye, C.A. ; Rajaram, M.V.S. ; Schlesinger, L.S. ; Tao, L. ; Brown, G.D. ; Langdon, Wallace Y. ; Li, B.T. ; Zhang, J. / Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. In: Nature Medicine. 2016 ; Vol. 22, No. 8. pp. 906-914.
@article{5975b8054c544a9e9125110fa00bf4e4,
title = "Targeting CBLB as a potential therapeutic approach for disseminated candidiasis",
abstract = "{\circledC} 2016 Nature America, Inc. All rights reserved.Disseminated candidiasis has become one of the leading causes of hospital-acquired blood stream infections with high mobility and mortality. However, the molecular basis of host defense against disseminated candidiasis remains elusive, and treatment options are limited. Here we report that the E3 ubiquitin ligase CBLB directs polyubiquitination of dectin-1 and dectin-2, two key pattern-recognition receptors for sensing Candida albicans, and their downstream kinase SYK, thus inhibiting dectin-1- and dectin-2-mediated innate immune responses. CBLB deficiency or inactivation protects mice from systemic infection with a lethal dose of C. albicans, and deficiency of dectin-1, dectin-2, or both in Cblb-/- mice abrogates this protection. Notably, silencing the Cblb gene in vivo protects mice from lethal systemic C. albicans infection. Our data reveal that CBLB is crucial for homeostatic control of innate immune responses mediated by dectin-1 and dectin-2. Our data also indicate that CBLB represents a potential therapeutic target for protection from disseminated candidiasis.",
author = "Y. Xiao and J. Tang and H. Guo and Y. Zhao and R. Tang and S. Ouyang and Q. Zeng and C.A. Rappleye and M.V.S. Rajaram and L.S. Schlesinger and L. Tao and G.D. Brown and Langdon, {Wallace Y.} and B.T. Li and J. Zhang",
year = "2016",
doi = "10.1038/nm.4141",
language = "English",
volume = "22",
pages = "906--914",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group - Macmillan Publishers",
number = "8",

}

Xiao, Y, Tang, J, Guo, H, Zhao, Y, Tang, R, Ouyang, S, Zeng, Q, Rappleye, CA, Rajaram, MVS, Schlesinger, LS, Tao, L, Brown, GD, Langdon, WY, Li, BT & Zhang, J 2016, 'Targeting CBLB as a potential therapeutic approach for disseminated candidiasis' Nature Medicine, vol. 22, no. 8, pp. 906-914. https://doi.org/10.1038/nm.4141

Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. / Xiao, Y.; Tang, J.; Guo, H.; Zhao, Y.; Tang, R.; Ouyang, S.; Zeng, Q.; Rappleye, C.A.; Rajaram, M.V.S.; Schlesinger, L.S.; Tao, L.; Brown, G.D.; Langdon, Wallace Y.; Li, B.T.; Zhang, J.

In: Nature Medicine, Vol. 22, No. 8, 2016, p. 906-914.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeting CBLB as a potential therapeutic approach for disseminated candidiasis

AU - Xiao, Y.

AU - Tang, J.

AU - Guo, H.

AU - Zhao, Y.

AU - Tang, R.

AU - Ouyang, S.

AU - Zeng, Q.

AU - Rappleye, C.A.

AU - Rajaram, M.V.S.

AU - Schlesinger, L.S.

AU - Tao, L.

AU - Brown, G.D.

AU - Langdon, Wallace Y.

AU - Li, B.T.

AU - Zhang, J.

PY - 2016

Y1 - 2016

N2 - © 2016 Nature America, Inc. All rights reserved.Disseminated candidiasis has become one of the leading causes of hospital-acquired blood stream infections with high mobility and mortality. However, the molecular basis of host defense against disseminated candidiasis remains elusive, and treatment options are limited. Here we report that the E3 ubiquitin ligase CBLB directs polyubiquitination of dectin-1 and dectin-2, two key pattern-recognition receptors for sensing Candida albicans, and their downstream kinase SYK, thus inhibiting dectin-1- and dectin-2-mediated innate immune responses. CBLB deficiency or inactivation protects mice from systemic infection with a lethal dose of C. albicans, and deficiency of dectin-1, dectin-2, or both in Cblb-/- mice abrogates this protection. Notably, silencing the Cblb gene in vivo protects mice from lethal systemic C. albicans infection. Our data reveal that CBLB is crucial for homeostatic control of innate immune responses mediated by dectin-1 and dectin-2. Our data also indicate that CBLB represents a potential therapeutic target for protection from disseminated candidiasis.

AB - © 2016 Nature America, Inc. All rights reserved.Disseminated candidiasis has become one of the leading causes of hospital-acquired blood stream infections with high mobility and mortality. However, the molecular basis of host defense against disseminated candidiasis remains elusive, and treatment options are limited. Here we report that the E3 ubiquitin ligase CBLB directs polyubiquitination of dectin-1 and dectin-2, two key pattern-recognition receptors for sensing Candida albicans, and their downstream kinase SYK, thus inhibiting dectin-1- and dectin-2-mediated innate immune responses. CBLB deficiency or inactivation protects mice from systemic infection with a lethal dose of C. albicans, and deficiency of dectin-1, dectin-2, or both in Cblb-/- mice abrogates this protection. Notably, silencing the Cblb gene in vivo protects mice from lethal systemic C. albicans infection. Our data reveal that CBLB is crucial for homeostatic control of innate immune responses mediated by dectin-1 and dectin-2. Our data also indicate that CBLB represents a potential therapeutic target for protection from disseminated candidiasis.

U2 - 10.1038/nm.4141

DO - 10.1038/nm.4141

M3 - Article

VL - 22

SP - 906

EP - 914

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 8

ER -